TY  - RPRT
TI  - A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.
AU  - Gerald G Krueger
AU  - Kim A Papp
AU  - Dow B Stough
AU  - Keith H Loven
AU  - Wayne P Gulliver
AU  - Charles N Ellis
AU  - Alefacept Clinical Study Group
PY  - 2002
DO  - 10.1067/mjd.2002.127247
UR  - https://pubmed.ncbi.nlm.nih.gov/12451365/
ID  - 12451365
ER  -